These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28836303)

  • 41. LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products.
    Vishnuvardhan C; Saibaba B; Allakonda L; Swain D; Gananadhamu S; Srinivas R; Satheeshkumar N
    J Pharm Biomed Anal; 2017 Feb; 134():1-10. PubMed ID: 27866053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Forced degradation of nepafenac: Development and validation of stability indicating UHPLC method.
    Runje M; Babić S; Meštrović E; Nekola I; Dujmić-Vučinić Ž; Vojčić N
    J Pharm Biomed Anal; 2016 May; 123():42-52. PubMed ID: 26871279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of an analytical method for the determination of pimavanserin and its impurities applying analytical quality by design principles as a risk-based strategy.
    Radić I; Runje M; Babić S
    J Pharm Biomed Anal; 2021 Jul; 201():114091. PubMed ID: 33964725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
    Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
    J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.
    Grover P; Maheshwari S; Nagarajan K; Mehta L; Kumar S; Rastogi C
    J Pharm Biomed Anal; 2023 Jan; 223():115119. PubMed ID: 36343537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products.
    P J; Ch V; A L; V G M N; Ch N; N S
    J Pharm Biomed Anal; 2017 Mar; 136():148-155. PubMed ID: 28081501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using liquid chromatography quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance.
    Tidke M; Golla VM; Kushwah BS; Naik DD; Gananadhamu S
    Biomed Chromatogr; 2023 Aug; 37(8):e5636. PubMed ID: 37005769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Forced degradation study of racecadotril: Effect of co-solvent, characterization of degradation products by UHPLC-Q-TOF-MS/MS, NMR and cytotoxicity assay.
    Chiguru V; Lingesh A; R S; N S
    J Pharm Biomed Anal; 2016 Sep; 128():9-17. PubMed ID: 27209450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of potential degradation products of brexpiprazole by liquid chromatography/quadrupole-time-of-flight mass spectrometry and nuclear magnetic resonance, and prediction of their physicochemical properties by ADMET Predictor™.
    Kushwah BS; Singh S; Thummar MM; Balhara A; Samanthula G
    Rapid Commun Mass Spectrom; 2023 Jan; 37(1):e9415. PubMed ID: 36226712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.
    Chavan BB; Sawant V; Borkar RM; Ragampeta S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Mar; 166():139-146. PubMed ID: 30640044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective separation, detection of zotepine and mass spectral characterization of degradants by LC-MS/MS/QTOF.
    Talluri MVNK; Kandimalla NR; Bandu R; Chundi D; Marupaka R; Srinivas R
    J Pharm Anal; 2014 Apr; 4(2):107-116. PubMed ID: 29403872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets.
    Nalwade SU; Reddy VR; Rao DD; Morisetti NK
    J Pharm Biomed Anal; 2012 Jan; 57():109-14. PubMed ID: 21920688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of forced degradation products of pazopanib hydrochloride by UHPLC-Q-TOF/MS and in silico toxicity prediction.
    Patel PN; Kalariya PD; Sharma M; Garg P; Talluri MV; Gananadhamu S; Srinivas R
    J Mass Spectrom; 2015 Jul; 50(7):918-28. PubMed ID: 26349647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage forms.
    Rao DD; Satyanarayana NV; Malleswara Reddy A; Sait SS; Chakole D; Mukkanti K
    J Pharm Biomed Anal; 2010 Feb; 51(3):736-42. PubMed ID: 19815361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Separation and characterization of forced degradation products in homoharringtonine injection by UHPLC-Q-TOF-MS.
    Gu X; Chen Y; Lou Y; Zheng J
    J Pharm Biomed Anal; 2019 Nov; 176():112801. PubMed ID: 31430625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation.
    Kumar N; Sangeetha D
    Sci Pharm; 2013; 81(3):697-711. PubMed ID: 24106668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of stability indicating assay method for mitapivat: Identification of novel hydrolytic, photolytic, and oxidative forced degradation products employing quadrupole-time of flight mass spectrometry.
    Bagul MA; Patil Y; Mane SS; Kunnath Shaji A; Das P; Ranjan OP; Dengale SJ
    J Sep Sci; 2024 Jul; 47(14):e2400173. PubMed ID: 39054589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of seven new related impurities and forced degradation products of tetracaine hydrochloride and proposal of degradation pathway by UHPLC-Q-TOF-MS.
    Liu C; Luo Y; Tao Q; Hong L; Zeng S
    J Pharm Biomed Anal; 2023 Jan; 223():115116. PubMed ID: 36343535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.